Companies' timelines for bringing new drugs to market may be impacted by the balancing act, which may result in variations in how quickly they can secure IND slots. Regulatory policies and practices gamesdlmay also be impacted by the way IND slots are managed. Regulatory bodies may need to modify their frameworks for assessing IND submissions as the pharmaceutical industry changes in response to scientific & technological breakthroughs. For example, conversations regarding how IND slots can support these cutting-edge methods have been sparked by the growth of biologics and personalized medicine.
e